Drug Profile
Research programme: scavenger receptor B1 modulators - KineMed
Alternative Names: SR-B1 therapeuticsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator KineMed
- Class
- Mechanism of Action SCARB1 protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Atherosclerosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Atherosclerosis in USA
- 15 May 2007 Preclinical trials in Atherosclerosis in USA (unspecified route)